Author name: lara.james

Just before the holiday period, our community voted on the most impactful scientific papers of the year authored by industry and regulatory experts and co-authored with Lhasa Limited. These awards recognise the work driving progress in toxicology and chemistry. They highlight the vital collaborative efforts between our scientists and industry partners, helping to shape the […]

The Science of Stability (SoS) 2025 conference, recently held in Philadelphia, brought together leading experts from the pharmaceutical industry and academia. Co-hosted by Lhasa Limited and FreeThink Technologies, this year’s event was a hub for collaboration and discussions. Attendees consistently praised the conference’s thematic structure and unparalleled networking opportunities, with many reporting a significant ‘increase in knowledge surrounding stability

The Brazilian Health Regulatory Agency (Anvisa) has introduced RDC 964/2025, a new guidance that outlines in more detail the requirements for conducting forced degradation studies. This new regulation replaces RDC 53/2015, aligning the requirements for forced degradation studies with international (ICH) standards. By reacting to these regulatory changes, Lhasa has evolved our solution for predicting

If you couldn’t join us for our recent webinar, “Identifying the Formation of Nitrosamines via Degradation Pathways Using an In-Silico Approach,” we’ve got you covered! We explored how Zeneth, our cutting-edge software solution, can help you detect potential degradation issues early in the drug development workflow, specifically in the context of nitrosamine risk assessment. We